Teng Xiong, Li Tian-Man, Peng Kai, Li Yu-Hua, Zhang Han-Jing, Ge Bin, Xie Hai-Xiang, Yang Ke-Jian, Qin Chong-Jiu, Liao Xi-Wen, Zhu Guang-Zhi, Zhou Xin, Peng Tao
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education, Nanning, China.
Transl Cancer Res. 2025 Aug 31;14(8):4882-4905. doi: 10.21037/tcr-2025-94. Epub 2025 Aug 27.
Lymph node metastasis (LNM) is one of the forms of hepatocellular carcinoma (HCC) dissemination, a phenomenon that is strongly correlated with an adverse prognosis. The transcription factor has been implicated in tumor progression in other malignancies, but its prognostic significance and mechanistic role in HCC LNM remain unexplored. This study aims to explore the prognostic significance and mechanistic role of the transcription factor in HCC LNM.
We retrospectively enrolled 387 HCC patients who underwent radical hepatectomy with lymph-node dissection between 2013 and 2021, among whom 57 were LNM-positive and the remaining 330 were negative. Recurrence-free survival (RFS) and overall survival (OS) were estimated using Kaplan-Meier curves and compared by log-rank test; independent prognostic factors were identified with Cox proportional-hazards regression. mRNA levels in matched primary tumors and metastatic lymph nodes were quantified by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Functional impacts of knockdown and overexpression were assessed in HCC cell lines via proliferation, migration, and invasion assays. Changes in epithelial-mesenchymal transition (EMT) markers (E-cadherin, N-cadherin, Vimentin) were examined by Western blot.
LNM, microvascular invasion (MVI), and the China Liver Cancer (CNLC) stage emerged as independent predictors of both shorter RFS and OS in the matched cohort; metastatic lymph nodes exhibited a 3.8-fold increase in mRNA compared to primary tumors (P<0.001). , knockdown significantly inhibited HCC cell proliferation, migration, and invasion, whereas overexpression produced the opposite effects. At the molecular level, modulation altered EMT marker expression-specifically, overexpression reduced E-cadherin while upregulating N-cadherin and Vimentin-demonstrating that drives EMT to promote HCC cell invasiveness and metastatic potential.
In summation, this study established a correlation between LNM and diminished RFS and OS among HCC patients. Moreover, it demonstrated the significant role of in HCC progression and LNM, which appears to modulate the malignant phenotype of HCC cells, encompassing enhanced proliferation, stem cell-like properties, and invasive migration through the induction of EMT. These collective findings implicate as a promising candidate for targeted therapeutic intervention in HCC.
淋巴结转移(LNM)是肝细胞癌(HCC)播散的形式之一,这一现象与不良预后密切相关。转录因子 在其他恶性肿瘤的肿瘤进展中发挥作用,但其在HCC-LNM中的预后意义和机制作用仍未得到探索。本研究旨在探讨转录因子 在HCC-LNM中的预后意义和机制作用。
我们回顾性纳入了2013年至2021年间接受根治性肝切除术并进行淋巴结清扫的387例HCC患者,其中57例LNM阳性,其余330例为阴性。采用Kaplan-Meier曲线估计无复发生存期(RFS)和总生存期(OS),并通过对数秩检验进行比较;通过Cox比例风险回归确定独立预后因素。通过逆转录定量聚合酶链反应(RT-qPCR)对配对的原发性肿瘤和转移性淋巴结中的 mRNA水平进行定量。通过增殖、迁移和侵袭试验评估 敲低和过表达对HCC细胞系的功能影响。通过蛋白质免疫印迹法检测上皮-间质转化(EMT)标志物(E-钙黏蛋白、N-钙黏蛋白、波形蛋白)的变化。
在配对队列中,LNM、微血管侵犯(MVI)和中国肝癌(CNLC)分期是RFS和OS缩短的独立预测因素;与原发性肿瘤相比,转移性淋巴结中的 mRNA增加了3.8倍(P<0.001)。 敲低显著抑制HCC细胞增殖、迁移和侵袭,而过表达则产生相反的效果。在分子水平上, 调节改变了EMT标志物的表达,具体而言, 过表达降低了E-钙黏蛋白,同时上调了N-钙黏蛋白和波形蛋白,表明 通过驱动EMT促进HCC细胞的侵袭性和转移潜能。
总之,本研究建立了HCC患者中LNM与RFS和OS降低之间的相关性。此外,它证明了 在HCC进展和LNM中的重要作用,其似乎通过诱导EMT调节HCC细胞的恶性表型,包括增强增殖、干细胞样特性和侵袭性迁移。这些共同发现表明 是HCC靶向治疗干预的有希望候选者。